Scenario.press - libera espressione Scenario.press - libera espressione
Résultats de Recherche
Voir tous les résulats
  • Nous rejoindre
    Se connecter
    S’enregistrer
    Rechercher
    Mode nuit

Rechercher

Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis

  • Fil d’actualités
  • EXPLORER
  • Pages
  • Groupes
  • Evènements
  • Blogs
  • Marketplace
  • Financement
  • Offres
  • Emplois
  • Courses
  • Film
  • Développeurs
  • Articles
  • Blogs
  • Utilisateurs
  • Pages
  • Groupes
  • Evènements
  • guptatanmayuds1308 Ajouter une nouvelle offre d'emploi Autre
    2025-06-25 07:08:13 -
    Adeno-Associated Virus (AAV) Gene Therapy Market Outlook: Technological Advancements & Forecast (2024–2032) | UnivDatos
    According to a new report by Univdatos, Adeno-Associated Virus Gene Therapy Market, is expected to reach USD 70 Billion in 2032 by growing at a CAGR of 39%. Adeno-Associated Virus (AAV) gene therapy has emerged as a groundbreaking approach in the treatment of various genetic and acquired disorders. In the United States, the field has seen remarkable advancements, with numerous clinical trials...
    0 Commentaires 0 Parts 785 Vue
    Connectez-vous pour aimer, partager et commenter!
  • vikasdada Ajouter une nouvelle offre d'emploi Autre
    2025-08-19 10:22:13 -
    Global CRISPR Gene-Editing Market Overview, Growth Analysis, Trends and Forecast By 2032
    "Regional Overview of Executive Summary CRISPR Gene-Editing Market by Size and Share The global CRISPR gene-editing market size was valued at USD 1.83 billion in 2024 and is expected to reach USD 14.74 billion by 2032, at a CAGR of 29.8% during the forecast period A consistent market research report like CRISPR Gene-Editing Market report extends reach to the...
    0 Commentaires 0 Parts 124 Vue
    Connectez-vous pour aimer, partager et commenter!
© 2025 Scenario.press - libera espressione French
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About us Terms & Conditions Confidentialité Business Model Dons Contactez nous Annuaire